Amber Therapeutics Secures $100M To Develop Neuromodulation For Mixed Urinary Incontinence

 
• By Marion Webb
  
Urinary Incontinence
• Source: Shutterstock
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Financing

More from Business